Ocular Therapeutix Inc Forecast, price target & analysts
Ocular Therapeutix Inc Target price 2026 - Analyst rating & recommendation
Ocular Therapeutix Inc Classifications & Recommendation
Ocular Therapeutix Inc Price Target
| Target Price | $28.56 |
| Price | $9.65 |
| Potential |
195.96%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Ocular Therapeutix Inc 2027 .
The average Ocular Therapeutix Inc target price is $28.56.
This is
195.96%
register free of charge
$35.70
269.95%
register free of charge
$18.18
88.39%
register free of charge
|
|
| A rating was issued by 18 analysts: 17 Analysts recommend Ocular Therapeutix Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ocular Therapeutix Inc stock has an average upside potential 2027 of
195.96%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 51.95 | 53.91 |
| 18.47% | 3.77% | |
| EBITDA Margin | -511.43% | -643.33% |
| 93.98% | 25.79% | |
| Net Margin | -511.92% | -627.12% |
| 68.57% | 22.50% |
14 Analysts have issued a sales forecast Ocular Therapeutix Inc 2026 . The average Ocular Therapeutix Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Ocular Therapeutix Inc EBITDA forecast 2026. The average Ocular Therapeutix Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
14 Ocular Therapeutix Inc Analysts have issued a net profit forecast 2026. The average Ocular Therapeutix Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.42 | -1.54 |
| 16.39% | 8.45% | |
| P/E | negative | |
| EV/Sales | 29.56 |
14 Analysts have issued a Ocular Therapeutix Inc forecast for earnings per share. The average Ocular Therapeutix Inc EPS is
This results in the following potential growth metrics and future valuations:
Ocular Therapeutix Inc...
Current Ocular Therapeutix Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Chardan Capital |
Locked
➜
Locked
|
Locked | Sep 16 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 16 2026 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | May 06 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Sep 16 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 16 2026 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Jun 25 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
May 06 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
